Clinical Trial Update: Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing chemotherapy with Strontium-89 versus chemotherapy alone in prostate cancer was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Strontium-89 (strontium-89)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2016-03-22